Lindbrook Capital, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Lindbrook Capital, LLC

  • $1.06 Billion
  • Q2 2024

A detailed history of Lindbrook Capital, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 79 shares of RARE stock, worth $4,299. This represents 0.0% of its overall portfolio holdings.

Number of Shares
79
Previous 117 32.48%
Holding current value
$4,299
Previous $5,000 40.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024
SELL
$37.42 - $51.61 $1,421 - $1,961
-38 Reduced 32.48%
79 $3,000
Q1 2024

Apr 25, 2024
BUY
$43.02 - $53.69 $774 - $966
18 Added 18.18%
117 $5,000
Q4 2023

Jan 31, 2024
BUY
$31.73 - $49.19 $444 - $688
14 Added 16.47%
99 $4,000
Q3 2023

Oct 25, 2023
SELL
$34.92 - $46.66 $4,714 - $6,299
-135 Reduced 61.36%
85 $3,000
Q2 2023

Jul 28, 2023
BUY
$37.35 - $52.15 $1,045 - $1,460
28 Added 14.58%
220 $10,000
Q1 2023

Apr 26, 2023
SELL
$36.99 - $48.71 $9,173 - $12,080
-248 Reduced 56.36%
192 $7,000
Q4 2022

Jan 24, 2023
BUY
$33.72 - $46.33 $10,992 - $15,103
326 Added 285.96%
440 $0
Q3 2022

Nov 10, 2022
BUY
$39.96 - $66.14 $4,555 - $7,539
114 New
114 $5,000
Q2 2022

Aug 01, 2022
SELL
$45.8 - $85.4 $1,282 - $2,391
-28 Closed
0 $0
Q1 2022

Apr 21, 2022
BUY
$62.2 - $84.4 $248 - $337
4 Added 16.67%
28 $2,000
Q4 2021

Jan 18, 2022
BUY
$73.71 - $87.86 $1,769 - $2,108
24 New
24 $2,000
Q2 2021

Jul 27, 2021
SELL
$92.19 - $115.71 $645 - $809
-7 Closed
0 $0
Q1 2021

Apr 28, 2021
BUY
$106.9 - $167.73 $748 - $1,174
7 New
7 $1,000
Q1 2020

Apr 22, 2020
SELL
$33.8 - $62.9 $574 - $1,069
-17 Closed
0 $0
Q4 2019

Jan 27, 2020
SELL
$36.08 - $45.83 $2,525 - $3,208
-70 Reduced 80.46%
17 $1,000
Q3 2019

Oct 31, 2019
BUY
$42.5 - $63.11 $1,020 - $1,514
24 Added 38.1%
87 $4,000
Q4 2018

Feb 07, 2019
BUY
$38.89 - $77.3 $2,450 - $4,869
63 New
63 $2,000

Others Institutions Holding RARE

# of Institutions
287
Shares Held
88.1M
Call Options Held
505K
Put Options Held
198K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.81B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email